Validation of the Scandinavian Guidelines for Minor and Moderate Head Trauma in Children
NCT ID: NCT05964764
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
5300 participants
OBSERVATIONAL
2018-04-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The goal of this observational study is to evaluate a Scandinavian tool developed to aid in management of children with head injuries seeking care in an emergency department.
The main research question is:
\- Are the Scandinavian guidelines for management of mild and moderate head trauma in children sensitive for patient-important outcomes?
Patients will be given the same treatment and recommendations for their head injury no matter if they participate or not in the study, as there is no intervention/ treatment group.
The doctor or nurse managing the child will collect information on patient history, signs and symptoms in the emergency department and management in an electronic case report form. Information on how the recovery period is collected both from medical records \>1 month after the emergency department visit, as well as via electronic questionnaires sent to the guardian at 1 month, 3 months and 4 months after the injury via e-mail and/or text message. Long-term outcome will also be examined (\>6 months).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of the Scandinavian Guidelines for Management of TBI in Adults
NCT03280485
Mild Traumatic Brain Injury and the Risk for Traumatic Intracranial Hemorrhage
NCT05609721
Clinical Decision Rule for Pediatric Intracranial Pathology
NCT02742272
Delayed IntraCranial Hemorrhage in Oral AntiCoagulant Treated Patients With Mild Traumatic Brain Injury
NCT07195760
Study of Antithrombotic Treatment After IntraCerebral Haemorrhage
NCT03186729
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a pragmatic, prospective, multicentre, observational study of children presenting with mild or moderate traumatic brain injury (TBI) in a general or paediatric emergency department (ED) at hospitals in Scandinavia. A complete data set for analysis including predictor variables and outcome data for the six guidelines included in the study will be registered (SNC2016, PECARN, CATCH, CHALICE, PREDICT, NICE23). There are no interventions as the study is observational. Attending physicians and nurses are instructed to manage children in accordance with the hospital's ordinary guidelines and follow local treatment traditions.
Study setting and population:
The study will be set in Sweden and Norway. Hospitals with different trauma capacities will participate; invitations are sent to units which on daily basis mange children with TBI in their department. Efforts are made to establish a representative distribution in participating centres. The coordinating centre is Halmstad Hospital in southern Sweden.
Data registration and follow-up:
Information on management in the emergency department including patient characteristics, injury type and mechanism, patient history, clinical examination results and current medications will be prospectively documented in a web- based case-report form by the triage nurse and/or physician on call.
One month after trauma, the local study coordinator will assess medical records and journals, screening for outcome measures as well as CT findings, when applicable. A follow-up questionnaire will be sent to guardian(s) 1 month, 3 months and 4 months after the child ́s head injury via e-mail and/or text message (long-term follow up at \>6 months). Reminders will be re-sent if no answer is received, primarily by e-mail and then twice by text message.
All data will be registered in via web-based case report forms in Entermedic (Entergate AB). Pseudo-anonymized data will be extracted from database and imported to IBM SPSS® Statistics software version 28 for statistical analysis.
Biomarkers:
A sub-study on patients with intermediate risk for intracranial injury and GCS 14-15, in selected study centres will explore biomarkers as predictors for intracranial injury. Venous blood, capillary blood and saliva sample is sampled from the patient in the ED after written informed consent. Sampling is done within 12 hours from the time of the injury. Analysis of biomarker S100B and others, not yet specified, will be analysed in batch at end of sub-study period.
CT examinations:
CT scans are analysed by a board-certified radiologist on the centre where the exam is performed.
Statistics:
The accuracy of the (SNC) guidelines to predict the primary endpoint will be assessed by 95% confidence intervals (CI) for sensitivity, specificity, likelihood ratio, negative predictive value (NPV) and positive predictive value (PPV). Test performance for other internationally recognized clinical decision rules (PECARN, CATCH, CHALICE, NICE, PREDICT) will also be calculated both in application cohorts (defined by each rule specific inclusion and exclusion criteria) and in comparative cohorts (minor head injury cohort = all patients with GCS 13-15; all patient cohort). When assessing CDRs other than SNC16, both rule specific endpoints and in-study defined endpoints will be tested. Secondary endpoints will be assessed using the same methods. Biomarker analysis results in ROC curves for sensitivity / specificity and from these are specific cut-offs that maximize performance for negative predictive value (i.e., to avoid unnecessary CT examinations and/or admission) derived.
Sample size:
The investigators aim to include 5,300 children, but not more than more than 4 years of active enrolment.
Ethics:
Ethical approval was granted from the Regional Ethical Review Board in Lund (approval number 2017/238) and Ethical Review Board in Norway (approval number 1085). Informed verbal consent will be obtained and registered. Patients' data and social security number will be stored and handled accordingly to European Union General Data Protection Regulation (GDPR 2016/679) and applicable Swedish laws.
A detailed protocol describing study methodology and statistical methods will be published before end of inclusion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minor and moderate blunt head trauma (GCS 9 - 15) seeking medical assessment in an emergency department at a study hospital in Sweden or Norway.
* Within 24 hours of trauma.
* Informed oral consent from one guardian, and child if older than 14 years old, after receiving oral and written information about study.
Exclusion Criteria
* Patient included in other study that may affect the management/treatment in the emergency department.
* Penetrating head injury (as those will always receive a CT scan).
* Suspected child abuse / non-accidental trauma (NAT) denoted as suspected child abuse where the social services are informed (as they will always receive a CT scan).
* The patient is not a citizen in the participating country and hence difficult to follow up.
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Halmstad County Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fredrik Wickbom
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johan Undén, MD, PhD.
Role: STUDY_CHAIR
Region Halland and Lund University, Sweden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haukeland Universitetssjukehus
Haukeland, , Norway
Alingsås Lasarett
Alingsås, , Sweden
Mälarsjukhuset i Eskilsstuna
Eskilstuna, , Sweden
Drottning Silvias Barnsjukhus
Gothenburg, , Sweden
Halland Hospital Halmstad
Halmstad, , Sweden
Länssjukhuset Ryhov
Jönköping, , Sweden
Lasarettet i Ljungby
Ljungby, , Sweden
Skåne University Hospital, Lund
Lund, , Sweden
Skånes Universitetssjukhus Malmö
Malmo, , Sweden
Mora Lasarett
Mora, , Sweden
Örebro Universitetssjukhus
Örebro, , Sweden
Astrid Lindgren Childrens Hospital, Solna
Stockholm, , Sweden
Norra Älvsborgs Länssjukhus
Trollhättan, , Sweden
Norrland University Hospital, NUS
Umeå, , Sweden
Halland Hospital Varberg
Varberg, , Sweden
Ystad Lasarett
Ystad, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Aqeel Chaudhry, MD
Role: primary
Hanna Farahnoosh, MD
Role: primary
Sarah Thornberg, MD
Role: primary
Malin Johansson, MD
Role: primary
Jorge Sotoca Fernandez, MD
Role: primary
Jorge Sotoca Fernandez, MD
Role: primary
Anders Santoft, MD
Role: primary
Kristofer Kjellröier, MD
Role: primary
Beatrice Magnusson, MD, PhD
Role: primary
Rasmus Silfver, MD
Role: primary
Rachel Keeling, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Wickbom F, Thornberg S, Sotoca Fernandez J, Silfver R, Marklund N, Unden J; Scandinavian Neurotrauma Committee. Comparison of predictive tools for management of paediatric mild TBI: a prospective cohort study. EClinicalMedicine. 2025 Sep 9;88:103484. doi: 10.1016/j.eclinm.2025.103484. eCollection 2025 Oct.
Wickbom F, Calcagnile O, Marklund N, Unden J. Validation of the Scandinavian guidelines for minor and moderate head trauma in children: protocol for a pragmatic, prospective, observational, multicentre cohort study. BMJ Open. 2024 Apr 3;14(4):e078622. doi: 10.1136/bmjopen-2023-078622.
Related Links
Access external resources that provide additional context or updates about the study.
Study information page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
220871
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.